Fig. 4From: RETRACTED ARTICLE: Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathwayNF repressed EMT in U87MG and U251 cells. a, b The expression of E-cadherin, N-cadherin, and Vimentin after NF treatment (0–150 μM, 48 h). *P < 0.05, **P < 0.01 vs. control group. c Immunofluorescence assay (scale bar: 200 μm) of E-cadherin and Vimentin after NF treatment (30 μM, 48 h)Back to article page